DMD and Duchenne muscular dystrophy: We also illustrate the utility of the EEV platform-based ASO conjugate approach to neuromuscular disorders with 2 examples: (1) modulation of pre-mRNA splicing to promote high levels of exon skipping and dystrophin protein restoration in a DMD mouse model and (2) biomarker transcript reduction in 2 FSHD cell models.